|
|
News Breaks
|
November 16, 2009
|
| 12:31 EDT |  | ENMD |
| theflyonthewall.com: | EntreMed's ENMD-2076 active in solid and hematological cancers | | EntreMed announced the presentation of data for the Phase 1 study for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, in leukemia patients. The Company also announced that it has selected ovarian cancer as an initial Phase 2 indication. :theflyonthewall.com |
|
|
News For ENMD From The Last 14 Days Check below for free stories on ENMD the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 6, 2012
|
| 07:05 EDT | | ENMD |
|
|
January 30, 2012
|
| 12:00 EDT |  | ENMD |
|
|
|
|
|
Subscribe for More Information